US Based Biotech company seeks highly reputable and well-established distributors specializing in selling diagnostic tests or similar products.
Launching the first in class Rapid Screening test for Sickle Cell Disease -
- Rapid Point of Care test using only 1 ml of blood
- Extremely portable and compact
- Simple to use and appropriate for rural and semi-urban areas
- 99% Clinical Accuracy in Adults, Children, and Newborns.
- Noble Prize-winning CRISPR-Cas9 Technology now being used to address many ailments including Sickle Cell Disease.